Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
R&D channel feed
FDA approves Sanofi's RNAi drug for hemophilia A and B
3 months ago
FDA+
BioNTech details promising mid-stage data for its PD-L1xVEGF in aggressive lung cancer
3 months ago
Merck KGaA pays Abbisko $85M for full commercial rights to benign tumor drug
3 months ago
Deals
Merck details injectable Keytruda data as it awaits autumn FDA decision
3 months ago
Equillium says graft-versus-host drug fails Phase 3, stock dives
3 months ago
Candel to focus on non-squamous lung cancer following new survival data
3 months ago
FDA approves first drug for Prader-Willi syndrome, to tamp down insatiable hunger symptoms
3 months ago
FDA+
Exelixis’ primary cancer drug wins FDA approval for neuroendocrine tumors
3 months ago
Pharma
Small biotech joins list of health companies taking a trip to Trump's Mar-a-Lago
3 months ago
Pharma
J&J touts new survival data pitting lung cancer combo against AstraZeneca's rival
3 months ago
Pharma
Marketing
Wave strengthens case for accelerated approval, with more positive Duchenne data
3 months ago
The Endpoints Slack interview: Duke’s Pranam Chatterjee unpacks AI bio’s pretty picture fallacy
3 months ago
Epicrispr raises $68M, will start clinical trial of epigenetic editing for FSHD
3 months ago
Senate confirms Makary as FDA chief with agency cuts, return-to-office in force
3 months ago
Pharma
FDA+
Axsome reports Phase 3 win for Sunosi in adults with ADHD, with a high-dose caveat
3 months ago
Pharma
Exclusive: mRNA startup Turn Biotechnologies acquires Vesigen’s microvesicle delivery tech
3 months ago
Kezar toplines small Phase 2a dataset in autoimmune liver disease
3 months ago
GSK to research whether shingles vaccine can cut dementia risk
3 months ago
FDA's biologics chief stresses need for vaccine transmission data despite high costs to generate
3 months ago
FDA+
Two biotechs fail to beat or match Regeneron's Eylea in key trials
3 months ago
Novo Nordisk pays $200M upfront for China-based biotech’s triple-G obesity shot
3 months ago
Deals
Biogen plans to open new headquarters in Boston area in 2028
3 months ago
AstraZeneca puts $2.5B toward first vaccine factory and second R&D site in China
3 months ago
China
Manufacturing
CDC vaccine meeting, delayed earlier this year, is rescheduled
3 months ago
Pharma
First page
Previous page
9
10
11
12
13
14
15
Next page
Last page